Retraction Notice:TGF-b1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20 (Immunol Cell Biol, (2011), 90, (640-654), 10.1038/icb.2011.80);TGF-Β1 re-programs TLR4 signaling in L. donovani infection: Enhancement of SHP-1 and ubiquitin-editing enzyme A20

Immunology and Cell Biology

Volumn 90, Issue 6, 2012, Pages 640-654

  Das, Sushmita ^a   Pandey, Krishna ^a   Kumar, Ashish ^a   Sardar, Abul H ^a   Purkait, Bidyut ^a   Kumar, Manish ^a   Kumar, Sudeep ^b   Ravidas, Vidya N ^a   Roy, Syamal ^c   Singh, Dharmendra ^a   Das, Pradeep ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

A20; leishmaniasis; SHP 1; TGF b1; Toll like receptors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VANADATE SODIUM; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN A 20;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; INDIA; LEISHMANIA DONOVANI; MACROPHAGE ACTIVATION; MALE; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SRC HOMOLOGY DOMAIN; TH1 CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

LEISHMANIA DONOVANI;

EID: 84863723158     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1111/imcb.12609     Document Type: Erratum

References (55)

1. Leishmaniasis fact sheet: http://www.who.int/tdr/diseases/leish/ diseaseinfo.htm.
2. Gregory DJ, Olivier M. Subversion of host cell signalling by the protozoan parasite Leishmania. Parasitology 2005; 130: S27-S35.
3. Sacks D, Sher A. Evasion of innate immunity by parasitic protozoa. Nat Immunol 2002; 3: 1041-1047.
4. Scharton-Kersten T, Afonso LC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol 1995; 154: 5320-5330.
5. Iniesta V, Gómez-Nieto LC, Corraliza I. The inhibition of arginase by N (omega)-hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J Exp Med 2001; 193: 777-784.
6. McCall CE, Yoza BK. Gene silencing in severe systemic inflammation. Am J Respir Crit Care Med 2007; 75: 763-767.
7. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLRinduced chromatin modifications. Nature 2007; 447: 972-978.
8. Ben-Othman R, Dellagi K, Guizani-Tabbane L. Leishmania major parasites induced macrophage tolerance: Implication of MAPK and NF-kB pathways. Mol Immunol 2009; 46: 3438-3444.
9. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface Toll-like receptor 4 expression. J Immunol 2000; 164: 3476-3479.
10. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-787.
11. Kawagoe T, Sato S, Matsushita K, Kato H, Kumagai Y, Saitoh T et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 2008; 9: 581-582.
12. Sun SC. Deubiquitylation and regulation of the immune response. Nat Rev Immunol 2008; 8: 501-511.
13. Evans PC, Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 2004; 378: 727-734.
14. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C et al. The ubiquitinmodifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 2004; 5: 1052-1060.
15. Noel W, Raes G, Ghassabeh GH, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol 2004; 20: 126-133.
16. Barral-Netto M, Barral A, Brownell CE, Skeiky YA, Ellingsworth LR, Twardzik DR. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science 1992; 257: 545-548.
17. Massague J, Blain SW, Lo RS. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.
18. Banerjee R, Kumar S, Sen A, Mookerjee A, Roy S, Pal S et al. TGF-b-regulated tyrosine phosphatases induce lymphocyte apoptosis in Leishmania donovani-infected hamsters. Immunol Cell Biol 2010; 18: 466-474.
19. Park IK, Shultz LD, Letterio JJ, Gorham JD. TGF-beta1 inhibits T-bet induction by IFNgamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1. J Immunol 2005; 175: 5666-5674.
20. Tsui FW, Martin A, Wang J, Tsui HW. Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1. Immunol Res 2006; 35: 127-136.
21. Kamata T, Yamashita M, Kimura M, Murata K, Inami M, Shimizu C et al. Src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest 2003; 111: 109-119.
22. Forget G, Gregory DJ, Whitcombe LA, Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect Immun 2006; 74: 6272-6279.
23. Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C et al. Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication. J Leukoc Biol 2004; 76: 48-57.
24. Nandan D, Yi T, Lopez M, Lai C, Reiner NE. Leishmania EF-1a activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J Biol Chem 2002; 277: 50190-50197.
25. Abu-Dayyeh I, Shio MT, Sato S, Akira S, Cousineau B, Olivier M. Leishmania-induced IRAK-1 inactivation is mediated by SHP-1 interacting with an evolutionarily conserved KTIM motif. PLoS Negl Trop Dis 2008; 2: e305.
26. Yamin TT, Miller DK. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J Biol Chem 1997; 272: 21540-21547.
27. Mizel SB, Snipes JA. Gram-negative flagellin-induced self-tolerance is associated with a block in interleukin-1 receptor-associated kinase release from toll-like receptor 5. J Biol Chem 2002; 277: 22414-22420.
28. Siedlar M, Frankenberger M, Benkhart E, Espevik T, Quirling M, Brand K et al. Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol 2004; 173: 2736-2745.
29. Song HY, Rothe M, Goeddel DV. The tumor necrosis factor inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kB activation. Proc Natl Acad Sci USA 1996; 93: 6721-6725.
30. Mosser DM, Rosenthal LA. Leishmania-macrophage interactions: multiple receptors, multiple ligands, and diverse cellular responses. Semin Cell Biol 1993; 4: 315-322.
31. Xiong Y, Qiu F, Piao W, Song C, Wahl LM, Medvedev AE. Endotoxin tolerance impairs Irak4 and Tak1 activation, K63-linked polyubiquitination and assembly of Irak1, Traf6, Ikkg, and increases A20 expression. J Biol Chem 2011; 286: 7905-7916.
32. Kim L, Butcher BA, Denkers EY. Toxoplasma gondii interferes with lipopolysaccharideinduced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. J Immunol 2004; 172: 3003-3010.
33. Telepnev M, Golovliov I, Grundström T, Tarnvik A, Sjöstedt A. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signaling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell Microbiol 2003; 5: 41-51.
34. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988; 334: 260-262.
35. Seabraa SH, de Souzab W, DaMatta RA. Toxoplasma gondii exposes phosphatidylserine inducing a TGF-b1 autocrine effect orchestrating macrophage evasion. Biochem Biophys Res Commun 2004; 324: 744-752.
36. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002; 109: 41-50.
37. Denys A, Udalova IA, Smith C, Williams LM, Ciesielski CJ, Campbell J et al. Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. J Immunol 2002; 168: 4837-4845.
38. Horst OV, Tompkins KA, Coats SR, Braham PH, Darveau RP, Dale BA. TGF-b1 inhibits TLR-mediated odontoblast responses to oral bacteria. J Dent Res 2009; 88: 333-338.
39. Forget G, Siminovitch KA, Brochu S, Rivest S, Radzioch D, Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur J Immunol 2001; 31: 3185-3196.
40. An H, Hou J, Zhou J, Zhao W, Xu H. Phosphatase SHP-1 promotes TLR-and RIG-Iactivated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 2008; 9: 542-550.
41. Zhou D, Collins CA, Wu P, Brown EJ. Protein tyrosine phosphatase SHP-1 positively regulates TLR-induced IL-12p40 production in macrophages through inhibition of phosphatidylinositol 3-kinase. J Leukoc Biol 2010; 87: 845-855.
42. Forget G, Matte C, Siminovitch KA, Rivest S, Pouliot P. Regulation of the Leishmaniainduced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur J Immunol 2005; 35: 1906-1917.
43. O'Neill LA. 'Fine tuning' TLR signaling. Nat Immunol 2008; 9: 459-461.
44. Adib-Conquy M, Cavaillon JM. Gamma interferon and granulocyte/monocyte colonystimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem 2002; 277: 27927-27934.
45. Jacinto R, Hartung T, McCall C, Li L. Lipopolysaccharide-and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase. J Immunol 2002; 168: 6136-6141.
46. Opipari Jr. AW, Boguski MS, Dixit VM. The A20 cDNA induced by tumor necrosis factor k encodes a novel type of zinc finger protein. J Biol Chem1990; 265: 14705-14708.
47. Hitotsumatsu O, Ahmad RC, Tavares R, Wang M, Philpott D, Turer EE et al. The ubiquitinediting enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity 2008; 28: 381-390.
48. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kB signalling. Nature 2004; 430: 694-699.
49. Coornaert B, Carpentier I, Beyaert R. A20: Central gatekeeper in inflammation and immunity. J Biol Chem 2009; 284: 8217-8221.
50. Subramaniam V, Li H, Wong M, Kitching R, Attisano L, Wrana J et al. The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer 2003; 89: 1538-1544.
51. Shembade N, Parvatiyar K, Harhaj NS, Harhaj EW. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kB signaling. EMBO J 2009; 28: 513-522.
52. Wang J, Ouyang Y, Guner Y, Ford HR, Grishin AV. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol 2009; 183: 1384-1392.
53. Scott P, Pearce E, Natovitz P, Sher A. Vaccination against cutaneous leishmaniasis in a murine model. II. Immunologic properties of protective and nonprotective subfractions of soluble promastigote extract. J Immunol 1987; 139: 3118-3125.
54. Olivier M, Romero-Gallo BJ, Matte C, Blanchette J, Posner BI. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J Biol Chem 1998; 273: 13944-13949.
55. Bhattacharyya (Majumdar) S, Dey R, Majumder N, Bhattacharjee S, Majumdar S. A novel approach to regulate experimental visceral leishmaniasis in murine macrophages using CCR5 siRNA. Scand J Immunol 2008; 67: 345-353.